NO994619L - Farmasöytiske blandinger - Google Patents

Farmasöytiske blandinger

Info

Publication number
NO994619L
NO994619L NO994619A NO994619A NO994619L NO 994619 L NO994619 L NO 994619L NO 994619 A NO994619 A NO 994619A NO 994619 A NO994619 A NO 994619A NO 994619 L NO994619 L NO 994619L
Authority
NO
Norway
Prior art keywords
pharmaceutical mixtures
pharmaceutical
mixtures
Prior art date
Application number
NO994619A
Other languages
English (en)
Other versions
NO326719B1 (no
NO994619D0 (no
Inventor
Warren Michael Casey
Ngoc-Anh Thi Nguyen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706295.4A external-priority patent/GB9706295D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO994619D0 publication Critical patent/NO994619D0/no
Publication of NO994619L publication Critical patent/NO994619L/no
Publication of NO326719B1 publication Critical patent/NO326719B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO994619A 1997-03-24 1999-09-23 Farmasøytiske blandinger, samt anvendelse og fremgangsmåte for fremstilling derav. NO326719B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation
PCT/EP1998/001626 WO1998042321A2 (en) 1997-03-24 1998-03-20 Liquid compositions comprising lamivudine

Publications (3)

Publication Number Publication Date
NO994619D0 NO994619D0 (no) 1999-09-23
NO994619L true NO994619L (no) 1999-11-23
NO326719B1 NO326719B1 (no) 2009-02-02

Family

ID=26311267

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994619A NO326719B1 (no) 1997-03-24 1999-09-23 Farmasøytiske blandinger, samt anvendelse og fremgangsmåte for fremstilling derav.

Country Status (40)

Country Link
US (1) US6004968A (no)
EP (1) EP0969815B1 (no)
JP (1) JP3264937B2 (no)
KR (1) KR100484695B1 (no)
CN (1) CN1191061C (no)
AP (1) AP1141A (no)
AR (1) AR011697A1 (no)
AT (1) ATE295150T1 (no)
AU (1) AU728461B2 (no)
BG (1) BG64690B1 (no)
BR (1) BR9808060B1 (no)
CA (1) CA2286126C (no)
CO (1) CO4980849A1 (no)
CY (1) CY2569B1 (no)
CZ (1) CZ298008B6 (no)
DE (1) DE69830154T2 (no)
EA (1) EA001990B1 (no)
EE (1) EE03996B1 (no)
ES (1) ES2239802T3 (no)
HK (1) HK1022853A1 (no)
HN (1) HN1998000045A (no)
HR (1) HRP980154B1 (no)
HU (1) HU225600B1 (no)
ID (1) ID29294A (no)
IL (1) IL131917A0 (no)
IS (1) IS2515B (no)
MY (1) MY116242A (no)
NO (1) NO326719B1 (no)
NZ (1) NZ337798A (no)
PA (1) PA8449301A1 (no)
PE (1) PE61699A1 (no)
PL (1) PL190505B1 (no)
PT (1) PT969815E (no)
RS (1) RS49772B (no)
SI (1) SI0969815T1 (no)
SK (1) SK283417B6 (no)
SV (1) SV1998000040A (no)
TW (1) TW536403B (no)
UY (1) UY24930A1 (no)
WO (1) WO1998042321A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544961B1 (en) 1996-06-25 2003-04-08 Smithkline Beecham Corporation Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV
US6018044A (en) * 1998-01-02 2000-01-25 Roche Vitamins Inc. Light screening compositions
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
JP2003039582A (ja) * 2001-07-19 2003-02-13 Three M Innovative Properties Co 湿潤防滑性シート及び湿潤防滑構造体
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
KR101235507B1 (ko) 2003-02-28 2013-02-20 추가이 세이야쿠 가부시키가이샤 단백질을 함유하는 안정화 제제
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
WO2009092002A1 (en) * 2008-01-17 2009-07-23 Duquesne University Of The Holy Spirit Antiretroviral drug formulations for treatment of children exposed to hiv/aids
RU2587782C1 (ru) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Стабильная фармацевтическая композиция ламивудина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
CA2286126C (en) 2003-08-12
CY2569B1 (en) 2008-07-02
CZ340399A3 (cs) 2000-04-12
JP2001501974A (ja) 2001-02-13
CA2286126A1 (en) 1998-10-01
KR100484695B1 (ko) 2005-04-22
UY24930A1 (es) 2000-10-31
ATE295150T1 (de) 2005-05-15
ID29294A (id) 2001-08-16
NO326719B1 (no) 2009-02-02
EP0969815B1 (en) 2005-05-11
HU225600B1 (en) 2007-05-02
SV1998000040A (es) 1999-03-16
CZ298008B6 (cs) 2007-05-23
ES2239802T3 (es) 2005-10-01
HUP0002982A3 (en) 2001-12-28
HRP980154B1 (en) 2002-06-30
AU7208498A (en) 1998-10-20
BR9808060A (pt) 2000-03-08
BG103818A (en) 2000-06-30
PT969815E (pt) 2005-07-29
CO4980849A1 (es) 2000-11-27
NO994619D0 (no) 1999-09-23
PE61699A1 (es) 1999-07-08
IS2515B (is) 2009-06-15
EA001990B1 (ru) 2001-10-22
AP9901657A0 (en) 1999-09-30
PA8449301A1 (es) 2000-05-24
BG64690B1 (bg) 2005-12-30
PL190505B1 (pl) 2005-12-30
DE69830154T2 (de) 2005-10-13
PL336038A1 (en) 2000-06-05
BR9808060B1 (pt) 2009-05-05
IS5184A (is) 1999-09-17
HK1022853A1 (en) 2000-08-25
CN1191061C (zh) 2005-03-02
SK283417B6 (sk) 2003-07-01
RS49772B (sr) 2008-06-05
EE9900440A (et) 2000-04-17
WO1998042321A3 (en) 1999-01-07
YU47799A (sh) 2002-06-19
HUP0002982A2 (hu) 2001-01-29
AU728461B2 (en) 2001-01-11
AP1141A (en) 2003-01-29
NZ337798A (en) 2001-03-30
WO1998042321A2 (en) 1998-10-01
SI0969815T1 (no) 2005-08-31
MY116242A (en) 2003-12-31
US6004968A (en) 1999-12-21
EP0969815A2 (en) 2000-01-12
JP3264937B2 (ja) 2002-03-11
DE69830154D1 (de) 2005-06-16
IL131917A0 (en) 2001-03-19
HN1998000045A (es) 1999-03-19
EE03996B1 (et) 2003-04-15
SK129999A3 (en) 2000-07-11
KR20010005624A (ko) 2001-01-15
EA199900757A1 (ru) 2000-08-28
AR011697A1 (es) 2000-08-30
HRP980154A2 (en) 1998-12-31
IL131917A (en) 2001-01-11
TW536403B (en) 2003-06-11
CN1255849A (zh) 2000-06-07

Similar Documents

Publication Publication Date Title
NO20001776D0 (no) Medikamenter
NO985337D0 (no) Tetrahydrolipstatin-holdige blandinger
ID24654A (id) Formulasi farmasi omeprazola
DK0783302T3 (da) Lægemidler
ID24176A (id) Bahan pembantu sementasi
DE69719823D1 (de) Blisterverpackung
NO980546D0 (no) Farmasöytiske midler
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
DE69820407D1 (de) Blisterpackung
NO985539D0 (no) Farmas°ytiske blandinger
DK1017392T3 (da) Lægemiddel
IS5331A (is) Ný lyfjablanda
ID27150A (id) Sediaan levotiroksin bahan farmasi
IS2150B (is) Statín-karboxýalkýleter-blöndur
NO994619D0 (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
DE69926012D1 (de) Arzneizubereitungen
DE69906934D1 (de) Arzneizubereitungen
ATE238786T1 (de) Anti-first-pass-effect-substanzen
ID23531A (id) Komposisi farmasi
ID21180A (id) Senyawa-senyawa farmasi
FR2772264B1 (fr) Pilulier
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
BR1100755A (pt) composição farmacêutica
UA25523A (uk) Лікувальhий препарат гірчичhик

Legal Events

Date Code Title Description
MK1K Patent expired